Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 4 institutions in 3 countries.
Daniel GündelDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04308 Leipzig, Germany.ORCID 0000-0001-9743-2325
Magali ToussaintDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04308 Leipzig, Germany.ORCID 0000-0002-1136-3857
Thu Hang LaiDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04308 Leipzig, Germany.ORCID 0000-0001-8157-8979
Winnie Deuther-ConradDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04308 Leipzig, Germany.ORCID 0000-0003-3168-3062
Paul CummingDepartment of Nuclear Medicine, Bern University Hospital, 3010 Bern, Switzerland.ORCID 0000-0002-0257-9621
Susann SchröderDepartment of Research and Development, ROTOP Pharmaka Ltd., 01328 Dresden, Germany.ORCID 0000-0001-6440-1362
Rodrigo TeodoroDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04308 Leipzig, Germany.
Rareş-Petru MoldovanDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04308 Leipzig, Germany.ORCID 0000-0003-3119-7945
Francisco Pan-MontojoDepartment of Psychiatry, University Hospital Munich, Ludwig-Maximilians-Universität (LMU) Munich, 80336 Munich, Germany.
Bernhard SattlerDepartment for Nuclear Medicine, University Hospital Leipzig, 04103 Leipzig, Germany.ORCID 0000-0003-3862-2609
Klaus KopkaDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04308 Leipzig, Germany.ORCID 0000-0003-4846-1271
Osama SabriDepartment for Nuclear Medicine, University Hospital Leipzig, 04103 Leipzig, Germany.
Peter BrustDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04308 Leipzig, Germany.ORCID 0000-0001-5555-7058
Helmholtz-Zentrum Dresden-Rossendorf · DEUniversity Hospital Leipzig · DELudwig-Maximilians-Universität München · DEQueensland University of Technology · AU
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Quantitation of the A · full record | OpenQuestion